Contrast media induced nephrotoxicity and prevention by N-acetylcysteine;Néphrotoxicité induite par les produits de contraste iodés et prévention par la N-acétylcystéine

Journal de Pharmacie Clinique

Volumn 23, Issue 1, 2004, Pages 19-23

  Khiem, A Tu Duy ^a   Gairard Dory, A C ^a   Alt, M ^a   Beretz, L ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Media contrast; N acetylcysteine; Nephrotoxicity

Indexed keywords

ACETYLCYSTEINE; CONTRAST MEDIUM; ISOTONIC SOLUTION; NONIONIC CONTRAST MEDIUM; SODIUM CHLORIDE;

ARTERIOGRAPHY; ARTICLE; CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; HIGH RISK PATIENT; HUMAN; HYDRATION; HYPOVOLEMIA; KIDNEY FAILURE; KIDNEY ISCHEMIA; KIDNEY METABOLISM; NEPHRON; NEPHROTOXICITY; PATHOPHYSIOLOGY; RISK FACTOR; VASOCONSTRICTION;

EID: 1942507315     PISSN: 02911981     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Berg KJ. Nephrotoxicity related to contrast media. Scand J Urol Nephrol 2000; 34: 317-22.
2. Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986; 104: 501-4.
3. Caro JJ, Trinade E, Mcgregor M. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media. A meta-analysis. Am J Roentgenol 1991; 156: 825-32.
4. Walday P, Heglund IF, Golman K, Cornacoff J, Holtz E. Renal effects of iodixanol in experimental animals. Acta Radiol Suppl 1995; 399: 204-12.
5. Deray G, Jacobs C. Radiocontrast nephrotoxicity. A review. Invest Radiol 1995; 30: 221-5.
6. Gerlach AT, Pickworth KK. Contrast medium-induced nephrotoxicity: pathophysiology and prevention. Pharmacotherapy 2000; 20: 540-8.
7. Vigeral P, Baumelou A, Benichou C, et al. Les insuffisances rénales d'origine médicamenteuses: résultats de réunion de consensus. Néphrologie 1989; 10: 157-61.
8. Freeman RV, O'Donnel M, Share D, et al. Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90: 1068-73.
9. MC Cullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368-75.
10. Morcos SK, Epstein FH, Haylor J, Dobrota M. Aspects of contrast media nephrotoxicity. Eur J Radiol 1996; 23: 178-84.
11. Meyrier A. Nephrotoxicity of iodine contrast media. Annal Radiol 1994; 37: 286-95.
12. Rauch D, Drescher P, Pereira FJ, Knes JM, Will JA, Madsen PO. Comparison of iodinated contrast media-induced renal vasoconstriction in human, rabit, dog, and pig arteries. Invest Radiol 1997; 32: 315-9.
13. Raininko R, Ylinen SL. Effect of ionic and non ionic contrast media on agregation of red blood cells in vitro. Acta Radiol 1987; 28: 87-93.
14. Amiel M, Eloy R. Les produits de contraste en angiographie, présents et futurs. J Radiol 1986; 67: 231-9.
15. Heyman SN, Brezis M, Reubinoff CA, et al. Acute renal failure with selective medullary injury in the rat. Clin Invest 1988; 82: 401-2.
16. Nygren A, Ulfendahl HR, Hansell P, Erikson U. Effects of intravenous contrast media in cortical and medullary blood flow in the rat kidney. Invest Radiol 1988; 23: 753-61.
17. Humes HD, Hunt DA, White MD. Direct toxic effect of the radiocontrast agent diatrizoate in renal proximal tubule cells. Am J Physiol 1987; 252: 246-55.
18. Cambell DR, Flemming BK, Mason WF, Jackson SA, Hirsch DJ, Mac Donald KJ. A comparative study of the nephrotoxicity of iohexol, iopamidol, and ioxaglate in peripheral angiography. Can Assoc Radiol J 1990; 41: 133-7.
19. Kahn JK, Rutherford BD, Macconahay DR, et al. High dose contrast agent administration during complex coronary angioplasty. Am Heart J 1990; 120: 533-6.
20. Barrett BJ, Carlisle EJ. Meta-analysis of the relative nephrotoxicity of high and low-osmolality iodinated contrast media. Radiology 1993; 188: 171-8.
21. Soma VR, Cavusoglu E, Vidhun R, Frishman WH, Sharma SK. Contrast associated nephropathy. Heart Dis 2002; 4: 372-9.
22. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency or both: a prospective controlled study. N Engl J Med 1989; 320: 143-9.
23. Levy EM, Viscoli CM, Horwitz EI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489-94.
24. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropapthy. J Am Soc Nephrol Contrast Nephropathy 2000; 11: 177-2.
25. Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491-9.
26. Stacul F, Cova M, Assante M, Hougens Grynne B, Haider T. Comparison between theefficacy of dimeric and monomeric non-ionic contrast media (iodixanol vs iopromide) in urography in patients with mild to moderate renal insufficiency. Br J Radiol 1998; 71: 918-22.
27. Stevens MA, Mccullough PA, Kenneth JT, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy. J AM Coll Cardiol 1999; 33: 403-11.
28. Kapoor A, Sinha N, Shrivastava SS, Radhakrishnan S, Goel PK, Bajaj R. Use of dopamine in prevention of contrast induced acute rena failure - A randomized study. Int J Cardiol 1996; 53: 533-236.
29. Abizaid AS, Clark CE, Mintz GS, et al. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol 1999; 83: 260-3.
30. Gare M, Haviv YS, Ben-Yehuda A, et al. The renal effect of low-dose dopamine in high risk patients undergoing coronary angiography. J Am Coll Cardiol 1999; 34: 1682-8.
31. Tumlin JA, Wang A, Murray PT, Mathur VS. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Am Heart J 2002; 143: 894-903.
32. Mueller C, Buerckle G, Buettner HJ, et al. Prevention of contrast media associated-nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-36.
33. Vogt B, Ferrari P, Schonholzer C, et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 2001; 111: 692-8.
34. Tepel M, Van Der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic contrast agent induced reductions in renal function by actylcysteine. N Engl J Med 2000; 343: 180-4.
35. Diaz-Sandoval LJ, Kosowsky B, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury. Am J Cardiol 2002; 89: 356-8.
36. Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002; 40: 1383-8.
37. Durham JD, Caputo C, Dokko J, et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephrophathy in cardiac angiography. Kidney Int 2002; 62: 2202-7.
38. Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003; 289: 606-8.
39. Allaqaband S, Tumuluri R, Malik AM, et al. Prospective randomized study of Nacetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 2002; 57: 279-83.
40. Briguori C, Manhanelli F, Pierfranco S, et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002; 40: 298-303.
41. Vallero A, Cesano G, Pozzato M, et al. Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine. G Ital Nefrol 2002; 19: 529-33.
42. Birck R, Krzossok S, Markowetz F, Schnulle P, Van Der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy. meta-analysis. Lancet 2003; 362: 598-603.
43. Kelly GS. Clinical applications of N-acetylcysteine. Altern Med Rev 1998; 3: 114-7.
44. Nowzari FB, Davidson SD, Eshghi M, Mallouh C, Tazaki H, Konho S. Adverse effects of oxidative stress on renal cells and its prevention by antioxidants. Mol Urol 2000; 4: 15-9.
45. Andrews NP, Prasad A, Quyyumi AA. N-acetylcysteine improves coronary and peripheral vascular function. J Am Coll Cardiol 2001; 37: 117-23.
46. Dimari J, Megyesi J, Udvarhelyi N, Price P, Davis R, Safirstein R. N-acetylcysteine ameliorates ischemic renal failure. Am J Physiol 1997; 272: F292-F298.